HBAN:NASDAQHuntington Bancshares Incorporated Analysis
Data as of 2026-03-10 - not real-time
$16.12
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Huntington Bancshares (HBAN) trades at $16.12, sitting below its 20‑day ($17.33) and 50‑day ($17.68) moving averages, with a RSI of 34.6 and a bearish MACD that suggest short‑term pressure, yet the stock remains comfortably above the identified support at $15.58. Fundamentally, the bank shows solid performance: revenue grew 10.3% YoY, operating margin stands at 39.8% and profit margin at 28.7%, while the P/E of 11.6 is well under the industry average of 17.4, indicating relative value. The dividend yield of 3.85% with a payout ratio of 44.6% appears sustainable, supported by positive operating cash flow and a strong cash position. Analyst sentiment is upbeat – the consensus recommendation is “Buy” with a median price target of $21 and a Morgan Stanley upgrade to $23, highlighting the stock’s upside potential of roughly 28% from the current level. Despite a 30‑day volatility of 34% and a beta above 1, the company’s regional focus, solid balance sheet, and dividend appeal mitigate broader market risks. In sum, HBAN presents a blend of value and growth characteristics, offering a compelling entry point for investors willing to navigate near‑term technical softness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages and bearish MACD
- RSI nearing oversold territory offering potential bounce
- Attractive dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 10% and strong operating margins
- Valuation metrics (P/E, DCF) suggest upside to analyst targets
- Analyst upgrades and raised price targets reinforce confidence
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend with moderate payout ratio
- Robust cash generation and manageable leverage
- Long‑term upside potential to $20‑$21 target price
Key Metrics & Analysis
Financial Health
Revenue Growth10.30%
Profit Margin28.74%
P/E Ratio11.6
ROE10.10%
ROA1.04%
P/B Ratio1.2
Op. Cash Flow$2.5B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI34.6
Support$15.58
Resistance$19.26
MA 20$17.33
MA 50$17.68
MA 200$16.85
MACDBearish
VolumeStable
Fear & Greed Index76.57
Valuation
Fair Value$15.91
Target Price$20.64
Upside/Downside28.06%
GradeFair
TypeBlend
Dividend Yield3.85%
Risk Assessment
Beta1.14
Volatility33.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.